Vance G. Fowler

1997–2025 年に発表

247
論文数
50,602
被引用数
112
h 指数
234
i10 指数

被引用数

Vance G. Fowler の年別被引用数1976 年: 被引用 1 件1979 年: 被引用 1 件1984 年: 被引用 2 件1997 年: 被引用 2 件1998 年: 被引用 5 件1999 年: 被引用 7 件2000 年: 被引用 16 件2001 年: 被引用 36 件2002 年: 被引用 39 件2003 年: 被引用 61 件2004 年: 被引用 101 件2005 年: 被引用 176 件2006 年: 被引用 198 件2007 年: 被引用 301 件2008 年: 被引用 238 件2009 年: 被引用 350 件2010 年: 被引用 281 件2011 年: 被引用 280 件2012 年: 被引用 260 件2013 年: 被引用 314 件2014 年: 被引用 335 件2015 年: 被引用 368 件2016 年: 被引用 296 件2017 年: 被引用 298 件2018 年: 被引用 331 件2019 年: 被引用 1,475 件2020 年: 被引用 1,576 件2021 年: 被引用 1,463 件2022 年: 被引用 1,334 件2023 年: 被引用 1,126 件2024 年: 被引用 1,996 件2025 年: 被引用 883 件2026 年: 被引用 21 件1977〜1978 年は被引用が無いため表示していません1980〜1983 年は被引用が無いため表示していません1985〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,806 件、この内訳の 25.4%中国: 引用元論文 1,309 件、この内訳の 8.7%イギリス: 引用元論文 836 件、この内訳の 5.6%イタリア: 引用元論文 641 件、この内訳の 4.3%ドイツ: 引用元論文 633 件、この内訳の 4.2%フランス: 引用元論文 605 件、この内訳の 4%スペイン: 引用元論文 562 件、この内訳の 3.7%カナダ: 引用元論文 454 件、この内訳の 3%オーストラリア: 引用元論文 449 件、この内訳の 3%オランダ: 引用元論文 388 件、この内訳の 2.6%スイス: 引用元論文 356 件、この内訳の 2.4%インド: 引用元論文 348 件、この内訳の 2.3%
0%25.4%その他 30.8%

分野

  • Medicine55.9%
  • Biochemistry, Genetics and Molecular Biology25.7%
  • Immunology and Microbiology7.8%
  • Agricultural and Biological Sciences2%
  • Environmental Science2%
  • Engineering1.5%
  • その他5.1%

トピック

  • Antimicrobial Resistance in Staphylococcus9.9%
  • Antibiotic Resistance in Bacteria6.5%
  • Infective Endocarditis Diagnosis and Management6%
  • Bacterial Identification and Susceptibility Testing5.1%
  • Bacterial biofilms and quorum sensing4.1%
  • Antibiotics Pharmacokinetics and Efficacy3.2%
  • その他65.2%

共著者

全論文

検索で開く
  1. Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

    著者: , , , , - Clinical Microbiology Reviews 2015 被引用: 5,092

  2. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research

    著者: , , , , , , , - Nature Reviews Microbiology 2019 被引用: 2,020

  3. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hiroaki Shimokawa, Irina Veze, Birutė Petrauskienė, Leon Salvador, John J.P. Kastelein, Jan H. Cornel, Tor Ole Klemsdal, Félix Medina, Andrzej Budaj, L Vida-Simiti, Zhanna Kobalava, Petar Otašević, Daniel Pella, Mitja Lainščak, Ki‐Bae Seung, Patrick Commerford, Mikael Dellborg, Marc Y. Donath, Juey‐Jen Hwang, Hakan Kültürsay, Marcus Flather, Christie M. Ballantyne, Seth Bilazarian, William H. Chang, Cara East, Brendan Everett, Les B. Forgosh, Robert J. Glynn, Barry Harris, Peter Libby, M Ligueros, Tom Thurén, Erin A. Bohula, Bindu Charmarthi, Susan Cheng, Sherry Chou, Jacqueline Suk Danik, Graham T. McMahon, Bradley A. Maron, MingMing Ning, Benjamin A. Olenchock, Reena L. Pande, Todd S. Perlstein, Aruna D. Pradhan, Natalia S. Rost, Aneesh B. Singhal, Viviany R. Taqueti, Nancy Wei, Howard A. Burris, Angela Cioffi, Anne Marie Dalseg, Nilanjan Ghosh, Julie R. Gralow, Tina Mayer, Hope S. Rugo, Vance G. Fowler, Ajit P. Limaye, Sara E. Cosgrove, Donald P. Levine, Renato D. Lópes, John Scott, Tom Thurén, M Ligueros, Robert Hilkert, Georgia Tamesby, Carolyn Mickel, Brian Manning, Julian Woelcke, Monique Tan, S Manfreda ほか 19 名 - The Lancet 2017 被引用: 1,308

  4. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

    著者: , , , , , , , , , , , , , , , - Circulation 2015 被引用: 3,171

  5. The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2023 被引用: 720

  6. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott Evans, Carol Hill, Keri Baum, Robert A. Bonomo, Barry N. Kreiswirth, María Virginia Villegas, Robin Patel, César A. Arias, Henry F. Chambers, Vance G. Fowler, Yohei Doi, David van Duin, Michael J. Satlin, Jinnethe Reyes, Lauren Komarow, Liang Chen, Lizhao Ge, Blake Hanson, Eric Cober, Erica Herc, Thamer H. Alenazi, Keith S. Kaye, Julia Garcia‐Diaz, Lanjuan Li, Souha S. Kanj, Zhengyin Liu, Jose M Oñate, Robert A. Salata, Kalisvar Marimuthu, Hainv Gao, Zhiyong Zong, Sandra Valderrama, Yunsong Yu, Paul Anantharajah Tambyah, Gregory Weston, Soraya Salcedo, Lillian M Abbo, Qing Xie, Karen Ordóñez, Minggui Wang, Martín E. Stryjewski, José M. Munita, David L. Paterson, Scott Evans, Carol Hill, Keri Baum, Robert A. Bonomo, Barry N. Kreiswirth, María Virginia Villegas, Robin Patel, César A. Arias, Henry F. Chambers, Vance G. Fowler, Yohei Doi, David van Duin, Michael J. Satlin - The Lancet Microbe 2023 被引用: 291

  7. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bettina C. Fries, Yohei Doi, Robin Patel, Barry N Kreiswirth, Robert A. Bonomo, Henry F. Chambers, Vance G. Fowler, César A. Arias, David van Duin, Lilian M. Abbo, Deverick J. Anderson, Rebekka M. Arias, César A. Arias, Keri Baum, Robert A. Bonomo, Henry F. Chambers, Liang Chen, Kean Lee Chew, Eric Cober, H. R. Cross, Partha Pratim De, Samit Desai, Sorabh Dhar, Valentina Di Castelnuovo, Lorena Díaz, An Q Dinh, Yohei Doi, Michelle Earley, Brandon Eilertson, Beth Evans, Scott Evans, Vance G. Fowler, Bettina C. Fries, Hainv Gao, Julia Garcia‐Diaz, Omai B. Garner, Kerryl E. Greenwood‐Quaintance, Blake Hanson, Erica Herc, Carol Hill, Jesse T. Jacob, Jianping Jiang, Robert C. Kalayjian, Souha S. Kanj, Keith S. Kaye, Angela Kim, Lauren Komarow, Barry N Kreiswirth, Courtney Lauterbach, Lanjuan Li, Zhengyin Liu, Claudia Manca, Kalisvar Marimuthu, Steven H. Marshall, Todd P McCarty, José M. Munita, Oon Tek Ng, Jose Millan Oñate Gutierrez, Karen Ordóñez, Robin Patel, David L. Paterson, Anton Y. Peleg, Jinnethe Reyes, Susan D. Rudin, Robert A. Salata, Soraya Salcedo, Michael J. Satlin, Suzannah M. Schmidt-Malan, Nares Smitasin, María Spencer ほか 14 名 - The Lancet Infectious Diseases 2021 被引用: 339

  8. Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis

    著者: , , , , , , , - Clinical Infectious Diseases 2000 被引用: 4,019

  9. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Henry F. Chambers, Vance G. Fowler, Barry N. Kreiswirth, Robert A. Bonomo - The Lancet Infectious Diseases 2020 被引用: 330

  10. Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

    著者: , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2017 被引用: 652

  11. Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms

    著者: , , , , - FEMS Microbiology Reviews 2019 被引用: 231

  12. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naomi Runnegar, David Andresen, Nicholas Anagnostou, Sandra Johnson, Mark D. Chatfield, Allen Cheng, Vance G. Fowler, Benjamin P. Howden, Niamh Meagher, David J. Price, Sebastiaan J. van Hal, Matthew O’Sullivan, Joshua S. Davis - JAMA 2020 被引用: 275

  13. Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

    著者: , , , , , - CA A Cancer Journal for Clinicians 2021 被引用: 188

  14. An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , G. Ralph Corey, Geoffrey S. Ginsburg, Charles B. Cairns, Ronny Otero, Vance G. Fowler, Emanuel P. Rivers, Christopher W. Woods, Stephen F. Kingsmore - Science Translational Medicine 2013 被引用: 511

  15. Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Keri Baum, Carol Hill, Barry N. Kreiswirth, Robin Patel, David L. Paterson, Cesar A Arias, Robert A. Bonomo, Henry F. Chambers, Vance G. Fowler, Michael J. Satlin, David van Duin, Yohei Doi, Multi-Drug Resistant Organism Network Investigators, Souha S. Kanj, Fujie Zhang, Judith J. Lok, Robert A. Salata, Martín E. Stryjewski, Valentina Di Castelnuovo, Jose Millan Oñate Gutierrez, Eric Cober, Susan Richter, Deverick J. Anderson, Beth Evans, Carol Hill, H. R. Cross, Keri Baum, Rebekka M. Arias, Vance G Fowler, Karen Ordóñez, Jesse T. Jacob, Linghua Li, Barry N Kreiswirth, Claudia Manca, Liang Chen, Samit Desai, Erica Herc, Ezequiel Córdova, María Luisa Rioseco, Samuel Vilchez, Marisa Sánchez, Sandra Valderrama, Jairo Figueroa, Cesar A Arias, An Q Dinh, Diane Panesso, Kirsten Rydell, Truc T. Tran, Fupin Hu, Jiachun Su, Jianping Jiang, Minggui Wang, Xiaogang Xu, Yang Yang, José M. Munita, María Spencer, Thamer H. Alenazi, Robert A. Bonomo, Steven H. Marshall, Susan D. Rudin, W. Charles Huskins, Kerry Greenwood-Quaintance, Robin Patel, Suzannah M. Schmidt-Malan, Sara Revolinski, Glenn Wortmann, Robert C. Kalayjian, Gregory Weston, Belinda Ostrowsky, Gopi Patel ほか 48 名 - Clinical Infectious Diseases 2023 被引用: 94

  16. Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)

    著者: , , , , , , , , , , , - Clinical Infectious Diseases 2015 被引用: 343

  17. Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2006 被引用: 1,463

  18. The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive Klebsiella pneumoniae in a Multi-Country Collection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raphael Simon, Alan S. Cross, Sharon M. Tennant - Frontiers in Microbiology 2020 被引用: 136

  19. Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 102

  20. Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis

    著者: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 被引用: 124

  21. Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?

    著者: , , , , , , , , , , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2017 被引用: 287

  22. Microbial Cell-Free DNA Identifies Etiology of Bloodstream Infections, Persists Longer Than Conventional Blood Cultures, and Its Duration of Detection Is Associated With Metastatic Infection in Patients With Staphylococcus aureus and Gram-Negative Bacteremia

    著者: , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2021 被引用: 91

  23. Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery

    著者: , , , , , , , , , , , , , , , , , - JAMA 2013 被引用: 365

  24. Infective endocarditis

    著者: , , , , , - Nature Reviews Disease Primers 2016 被引用: 397